Abeona Therapeutics Inc (ABEO)
R&D Expense Growth
-47.45%
Quarterly · Period ending:
ABEO R&D Expense Growth
Latest reported-47.45%period ending
Latest reported-47.45%period ending
ABEO Quarterly R&D Growth (QoQ) (0.00% → -47.45%)
Latest values, visible window
High-resolution chart · PNG
ABEO r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -47.4516% | |
| 42.357% | |
| 59.203% | |
| -29.0594% | |
| -40.2173% | |
| 10.5292% | |
| 0.5928% | |
| -3.005% | |
| 27.9034% | |
| -2.3309% | |
| 3.2317% | |
| -16.1328% | |
| 5.9943% | |
| 28.2047% | |
| 14.2441% | |
| -17.5428% | |
| -44.1864% | |
| -7.0371% | |
| 41.6961% | |
| 6.1291% | |
| 2.5971% | |
| -10.0184% | |
| 15.9869% | |
| 30.4469% | |
| -84.6253% | |
| 265.4037% | |
| -0.3939% | |
| -33.0533% | |
| 38.9367% | |
| 12.7474% | |
| -20.8365% | |
| 66.1193% | |
| -3.014% | |
| 43.0424% | |
| 74.1227% | |
| -43.5778% | |
| 164.2402% | |
| -27.6259% | |
| 10.6375% | |
| -9.0457% | |
| 62.6954% | |
| -16.3284% | |
| 40.2277% | |
| 159.1803% | |
| 34.6578% | |
| 1,194.2857% | |
| -52.0548% | |
| -9.8765% | |
| -43.75% | |
| 12.5% | |
| -45.7627% | |
| 19.797% | |
| -39.0093% | |
| 8.3893% | |
| -3.2468% | |
| -52.9052% | |
| -32.8542% | |
| 1.7764% | |
| -9.9718% | |
| 0.283% | |
| -5.3571% | |
| 77.496% | |
| -47.3728% | |
| 63.5744% | |
| -6.743% | |
| -4.9577% | |
| 47.4153% | |
| -3.6082% | |
| -15.2838% | |
| 36.0396% | |
| -60.6698% | |
| 8.9059% | |
| -87.776% | |
| 801.4019% | |
| 79.5302% | |
| 13.9579% | |
| 26.6344% | |
| 45.4225% | |
| -25.066% | |
| -40.2208% | |
| -16.1376% | |
| 186.9965% | |
| -311.9512% | |
| -71.5278% | |
| 9.1736% | |
| -16.8348% | |
| 12.8023% | |
| 9.758% | |
| 11.9755% | |
| -26.0982% | |
| 23.445% | |
| -16.2325% | |
| -16.6945% | |
| -0.6633% | |
| -17.0564% | |
| 27.4693% | |
| 29.3273% | |
| 56.7536% | |
| -34.8263% | |
| 25.4845% |